Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

FDA employees are reportedly eyeing exits amid talks of Robert F. Kennedy Jr. joining Trump's administration. Concerns extend ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results and ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Federal health scientists brace for RFK Jr.'s potential takeover, with some readying résumés or retirement plans.

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?